Challenging: Rupert Soames, chairman of Smith & Nephew, stressed the medical technology group has a ‘well-formed’ strategy
The chairman of Smith & Nephew has defended his strategy as pressure mounted from major investors calling for a break-up of the company.
Rupert Soames’ stance comes after The Mail on Sunday revealed that the medical technology group’s shareholders have put CEO Deepak Nath on notice to improve his fortunes or be ousted.
Smith & Nephew consists of three divisions: sports medicine, wound care and orthopedics – which makes knee and hip replacements and is considered ripe for a spin-off.
But Soames told the FT yesterday: ‘We have a well-articulated strategy and plan that we are diligently executing – it spans all three of our business areas.’
DIY INVESTMENT PLATFORMS
A. J. Bell
A. J. Bell
Easy investing and ready-made portfolios
Hargreaves Lansdown
Hargreaves Lansdown
Free fund trading and investment ideas
interactive investor
interactive investor
Invest for a fixed amount from € 4.99 per month
Sax
Sax
Get £200 back in trading fees
Trade 212
Trade 212
Free trading and no account fees
Affiliate links: If you purchase a product, This is Money may earn a commission. These deals have been chosen by our editors because we believe they are worth highlighting. This does not affect our editorial independence.